Press release
September 8, 2026
CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
CalciMedica, Inc. (CALC)
LA JOLLA, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- CalciMedica, Inc. (“CalciMedica” or the “Company”) (Nasdaq: CALC), a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for serious inflammatory, immunologic, and